- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07657962
Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty
Effect of Autologous Free Dermal Graft Use on Lower Pole Stability in Superior Pedicle Vertical Scar Reduction Mammaplasty: A Prospective Comparative Cohort Study
The goal of this observational study is to learn whether using an autologous free dermal graft during breast reduction surgery helps maintain lower breast pole shape over time in women undergoing primary bilateral reduction mammaplasty.
The main question it aims to answer is:
Does autologous free dermal graft support reduce lower pole lengthening between 1 month and 6 months after surgery?
Researchers will compare two groups of participants. One group will undergo superior pedicle vertical scar reduction mammaplasty with autologous free dermal graft support as part of routine surgical care. The other group will undergo the same basic breast reduction technique without autologous free dermal graft support.
Participants will:
- Have their planned breast reduction surgery as part of routine care
- Attend postoperative follow-up visits at 1, 3, and 6 months
- Have standard breast measurements and medical photographs taken during follow-up
- Complete a breast satisfaction questionnaire at 6 months
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Reduction mammaplasty is a well-established procedure performed for symptomatic breast hypertrophy and breast ptosis. In addition to volume reduction, the operation aims to achieve a durable breast shape, stable lower pole contour, and an appropriate nipple-areola complex position. However, even after technically successful surgery, postoperative breast morphology may change over time. Lower pole elongation, pseudoptosis, and bottoming-out remain relevant problems, particularly in patients with large resection volumes, poor tissue elasticity, or increased load on the lower pole.
Several internal support methods have been described to improve long-term shape stability after reduction mammaplasty. These include dermal suspension flaps, dermal bra techniques, parenchymal fixation sutures, and inframammary fold reinforcement. In the present study, we will evaluate an autologous support method in which de-epithelialized dermal tissue obtained during the operation is used as a free dermal graft and placed in the lower pole region. Unlike vascularized dermal flaps, this graft is not maintained on a vascular pedicle. This approach may provide a simple autologous support option without the need for synthetic or biological mesh material.
This study is planned as a prospective, single-center, observational, comparative cohort study. Participants undergoing primary bilateral superior pedicle vertical scar reduction mammaplasty will be followed with a standardized postoperative assessment protocol. The study will not include randomization or any study-related assignment to a surgical technique. The surgical approach will be determined according to the routine practice of the operating surgeon. In the same department, one routine approach includes autologous free dermal graft support in the lower pole, whereas the comparison approach uses the same basic superior pedicle vertical scar reduction mammaplasty technique without free dermal graft placement.
The planned enrollment is 70 participants. Sample size calculation was based on the expected between-group difference in postoperative lower pole change. A 1 cm difference was accepted as clinically meaningful, with an estimated standard deviation of 1.3 cm. Using G*Power 3.1, with a two-sided alpha level of 0.05, 80% power, an effect size of 0.77, and a 1:1 group ratio, at least 28 participants were required in each group. Considering possible loss to follow-up, the planned sample size was increased to 35 participants per group.
Demographic, clinical, operative, anthropometric, photographic, patient-reported, and postoperative safety data will be collected prospectively. Demographic and clinical variables will include age, body mass index, smoking history, comorbidities, pregnancy and breastfeeding history, and preoperative breast characteristics. Operative variables will include surgical group, resection weights, operative time, drain use, and routine perioperative data. Postoperative follow-up data will include serial breast measurements, standardized photographs, patient-reported satisfaction, complications, and clinically relevant postoperative events.
Anthropometric measurements will be obtained according to a standardized protocol. Measurements will be performed with the participant standing in a natural posture and with the arms relaxed. Right and left breast measurements will be recorded separately. For bilateral continuous breast measurements, the mean value of both breasts will be used for participant-level analysis. Standardized medical photographs will be obtained in predefined views and assessed by independent evaluators blinded to the surgical group.
Eligible participants will be evaluated consecutively during the recruitment period. Data will be recorded on predefined case report forms. Before analysis, range and consistency checks will be performed. When necessary, source data will be verified using clinical records. Missing data will be reviewed before final analysis. Participants without the required follow-up measurement for the primary analysis will not be included in the primary endpoint analysis, and the extent of missing data will be reported.
The statistical analysis will compare the two routine surgical approaches. Potential confounding factors, including baseline patient characteristics and operative variables, will be considered during analysis. The study is expected to provide prospective clinical data on the possible role of autologous free dermal graft support in maintaining lower pole stability after superior pedicle vertical scar reduction mammaplasty.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Murat Çelik, Assistant Professor
- Numéro de téléphone: +905546902104
- E-mail: mucetr@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Handan Derebaşınlıoğlu, Associate Professor
- Numéro de téléphone: 90 346 487 00 00
- E-mail: handanderebasinlioglu@gmail.com
Lieux d'étude
-
-
Sivas
-
Sivas, Sivas, Turquie (Türkiye), 58050
- Recrutement
- Sivas Cumhuriyet University
-
Contact:
- Handan Derebaşınlıoğlu, Associate Professor
- Numéro de téléphone: 90 346 487 00 00
- E-mail: handanderebasinlioglu@gmail.com
-
Contact:
- Murat Çelik, Assistant Professor
- Numéro de téléphone: 05546902104
- E-mail: mucetr@gmail.com
-
Chercheur principal:
- Murat Çelik, Assistant Professor
-
Sous-enquêteur:
- Handan Derebaşınlıoğlu, Associate Professor
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Female participants aged 18 to 65 years
- Planned primary bilateral reduction mammaplasty
- Planned use of the superior pedicle vertical scar technique
- Willingness to attend at least 6 months of postoperative follow-up
- Ability to provide written informed consent
- Consent for standardized medical photography and clinical breast measurements
Exclusion Criteria:
- Previous breast surgery
- Oncoplastic breast reduction
- Unilateral reduction mammaplasty
- Use of a pedicle technique other than the superior pedicle
- Use of a scar pattern other than the vertical scar pattern
- Presence of a systemic condition expected to significantly impair wound healing
- Active smoking within the last 6 weeks before surgery
- Incomplete 6-month follow-up data for the primary outcome analysis
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Autologous Free Dermal Graft Group
Participants undergoing primary bilateral superior pedicle vertical scar reduction mammaplasty with placement of a de-epithelialized autologous free dermal graft in the lower pole region as part of routine surgical practice.
No study-specific surgical assignment or randomization will be performed.
|
Placement of a de-epithelialized autologous free dermal graft in the lower pole region during superior pedicle vertical scar reduction mammaplasty.
The dermal graft is obtained from the participant's own de-epithelialized skin during the planned breast reduction procedure and is used as an autologous structural support method.
The graft is not vascularized and does not remain attached to a dermal or glandular pedicle.
No synthetic or biological mesh material is used.
Autres noms:
|
|
No Free Dermal Graft Group
Participants undergoing primary bilateral superior pedicle vertical scar reduction mammaplasty without placement of an autologous free dermal graft.
This group will receive the same basic reduction mammaplasty technique according to routine surgical practice, without study-specific surgical assignment or randomization.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Nipple-to-Inframammary Fold Distance
Délai: From postoperative month 1 to postoperative month 6
|
Change in nipple-to-inframammary fold distance will be calculated as the difference between the postoperative month 6 and postoperative month 1 measurements.
Measurements will be recorded in centimeters.
A positive value will indicate lower pole elongation.
Right and left breast measurements will be recorded separately, and the mean value of both breasts will be used for analysis.
|
From postoperative month 1 to postoperative month 6
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Sternal Notch-to-Nipple Distance
Délai: From postoperative month 1 to postoperative month 6
|
Change in sternal notch-to-nipple distance will be calculated as the difference between the postoperative month 6 and postoperative month 1 measurements.
Measurements will be recorded in centimeters.
A positive value will indicate inferior displacement of the nipple-areola complex.
Right and left breast measurements will be recorded separately, and the mean value of both breasts will be used for analysis.
|
From postoperative month 1 to postoperative month 6
|
|
Change in Lower Pole Ratio
Délai: From postoperative month 1 to postoperative month 6
|
The lower pole ratio will be calculated by dividing the nipple-to-inframammary fold distance by the sternal notch-to-nipple distance.
The change in lower pole ratio will be calculated as the difference between the postoperative month 6 and postoperative month 1 values.
Right and left breast ratios will be calculated separately, and the mean value of both breasts will be used for analysis.
|
From postoperative month 1 to postoperative month 6
|
|
Patient Satisfaction With Breasts
Délai: Postoperative month 6
|
Patient-reported satisfaction with breast appearance will be assessed at postoperative month 6 using the Satisfaction with Breasts scale of the BREAST-Q Reduction/Mastopexy module.
The total scale score will be used for analysis.
|
Postoperative month 6
|
|
Blinded Photographic Aesthetic Assessment
Délai: Preoperative period and postoperative month 6
|
Standardized preoperative and postoperative month 6 photographs will be evaluated by independent assessors blinded to surgical group.
Overall aesthetic change will be assessed using the Global Aesthetic Improvement Scale.
If more than one assessor evaluates the photographs, the mean assessor score will be used for analysis.
|
Preoperative period and postoperative month 6
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Breast Base Height-to-Width Ratio
Délai: From postoperative month 1 to postoperative month 6
|
Breast base height-to-width ratio will be calculated by dividing breast base height by breast base width.
Breast base height will be measured as the vertical distance between the superior breast border and the inframammary fold, and breast base width will be measured as the widest medial-to-lateral breast distance.
The change in this ratio will be calculated between postoperative month 1 and postoperative month 6.
Right and left breast ratios will be calculated separately, and the mean value of both breasts will be used for analysis.
|
From postoperative month 1 to postoperative month 6
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Murat Çelik, Assistant Professor, Cumhuriyet University
- Directeur d'études: Handan Derebaşınlıoğlu, Cumhuriyet University
Publications et liens utiles
Publications générales
- Qiao Q, Sun J, Liu C, Liu Z, Zhao R. Reduction mammaplasty and correction of ptosis: dermal bra technique. Plast Reconstr Surg. 2003 Mar;111(3):1122-30. doi: 10.1097/01.PRS.0000046806.64384.60.
- Hudson DA, Moodley S. Breast Reduction: Decreasing Complications and Improving Long-Term Aesthetic Results with Parenchymal Sutures. Plast Reconstr Surg Glob Open. 2017 Sep 19;5(9):e1470. doi: 10.1097/GOX.0000000000001470. eCollection 2017 Sep.
- Bitik O, Uzun H. Analysis of Lower Breast Pole Length and Nipple-Areola Complex Position Following Superior Pedicle, Short Horizontal Scar Breast Reduction. Aesthetic Plast Surg. 2016 Oct;40(5):690-8. doi: 10.1007/s00266-016-0663-4. Epub 2016 Jun 29.
- Wagner RD, Lisiecki JL, Chiodo MV, Rohrich RJ. Longevity of ptosis correction in mastopexy and reduction mammaplasty: A systematic review of techniques. JPRAS Open. 2022 May 13;34:1-9. doi: 10.1016/j.jpra.2022.05.003. eCollection 2022 Dec.
- Choi M, Unger J, Small K, Tepper O, Kumar N, Feldman D, Karp N. Defining the kinetics of breast pseudoptosis after reduction mammaplasty. Ann Plast Surg. 2009 May;62(5):518-22. doi: 10.1097/SAP.0b013e31819fb00c.
- Singh KA, Losken A. Additional benefits of reduction mammaplasty: a systematic review of the literature. Plast Reconstr Surg. 2012 Mar;129(3):562-570. doi: 10.1097/PRS.0b013e31824129ee.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 26_06_04_5
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .